Back
Nu Skin Enterprises Vs. Novo Nordisk AS Industry Stock Comparison
Sell
35
NUS
Nu Skin Enterprises
Last Price:
$6.38
Seasonality Move:
2.87%
Sell
9
NONOF
Novo Nordisk AS
Last Price:
$87.58
Seasonality Move:
9.09%
Sell
35
Nu Skin Enterprises (NUS)
is a Sell
Is Nu Skin Enterprises a Buy, Sell or Hold?
-
The current Nu Skin Enterprises [NUS] share price is $6.65. The Score for NUS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
NUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $85.04. The Score for NONOF is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NUS Stock Price Chart
What is Nu Skin Enterprises's stock price today?
-
The Nu Skin Enterprises share price today is $6.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUS is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
NUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 43.94 | Sell |
Chaikin Money Flow: | 30077 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.73 - 7.57) | Sell |
Bollinger Bands (100): | (6.32 - 8.34) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.19 | Sell |
Relative Strength Index (14 RSI): | 32.42 | Sell |
Chaikin Money Flow: | -1041 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.31 - 109.25) | Sell |
Bollinger Bands (100): | (99.35 - 129.37) | Sell |
NUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.86 | Sell |
20-day SMA: | 7.03 | Sell |
50-day SMA: | 7.08 | Sell |
200-day SMA: | 9.65 | Sell |
8-day EMA: | 6.87 | Sell |
20-day EMA: | 6.99 | Sell |
50-day EMA: | 7.14 | Sell |
200-day EMA: | 10.19 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.85 | Sell |
20-day SMA: | 94.98 | Sell |
50-day SMA: | 102.41 | Sell |
200-day SMA: | 123.63 | Sell |
8-day EMA: | 86.44 | Sell |
20-day EMA: | 92.43 | Sell |
50-day EMA: | 101.51 | Sell |
200-day EMA: | 114.69 | Sell |
Nu Skin Enterprises Earnings Growth & NUS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.60 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Nu Skin Enterprises Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |